Home/SEC 13D/G/COAGSEC 13D/GCOAG - Hemab Therapeutics Holdings, Inc. - SEC Filing Update (05-AUG-2026) | ThinkSabio - Stocks Simplified$COAG$48.11▲ 41.33% YTDHealthcareAug 5, 2026 · ThinkSabio BlogSEC Filing Update: #COAG Hemab Therapeutics Holdings, Inc. : $48.11 Sector: Healthcare | YTD: 🔼+ 41.33% The SEC disclosed Today (05-AUG-2026) that Sofinnova Crossover II SLP has Newly bought 2,511,212 #COAG shares Ownership: 5.4% * Estimated Investment Value: $118.00M https://www.thinksabio.com/reports/isr/COAG Share this post🔗Copy LinkMore filings for $COAGCOAG - Hemab Therapeutics Holdings, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026COAG - Hemab Therapeutics Holdings, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G